Aims/Hypothesis The relationships between smoking and glycaemic variables have not been well explored. We compared HbA 1c , fasting plasma glucose (FPG) and 2 h plasma glucose (2H-PG) in current, ex-and never-smokers. Methods This meta-analysis used individual data from 16,886 men and 18,539 women without known diabetes in 12 DETECT-2 consortium studies and in the French Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) and Telecom studies. Means of three glycaemic variables in current, ex-and never-smokers were modelled by linear regression, with study as a random factor. The I 2 statistic was used to evaluate heterogeneity among studies. Electronic supplementary material The online version of this article (doi:10.1007/s00125-013-3058-y) contains peer-reviewed but unedited supplementary material, which is available to authorised users.
Introduction
The prevalence of type 2 diabetes is still increasing. Providing current and future estimates of diabetes prevalence is essential for public health planning. It is also important to be aware of factors associated with screen-detected diabetes to interpret these prevalences, and to provide appropriate prevention programmes. In this study we investigate smoking, a recognised risk factor for diabetes: a meta-analysis by Willi et al reported a pooled adjusted relative risk (95% CI) for incident diabetes of 1.44 (1.31, 1.58) for current smokers compared with nonsmokers [1] .
An individual's phenotype and behavioural characteristics affect the chances of detecting diabetes by screening, according to whether fasting plasma glucose (FPG) or 2 h plasma glucose (2H-PG) following an OGTT is used [2, 3] ; this appears to also be the case for HbA 1c , in comparison with screen-detected diabetes using FPG or 2H-PG [4] . For participants in the Inter99 study who were screen-detected with diabetes by HbA 1c (but not by OGTT results), fewer had hypertension or raised triacylglycerols, but more smoked in comparison with those detected by the OGTT results (but not by HbA 1c ) [4] . This latter result led us to further investigate the link between smoking and these three glycaemic variables.
The association between smoking status and the glycaemic variables HbA 1c , FPG and 2H-PG has been studied, but few have studied all three variables in the same population. A higher HbA 1c was found in smokers in six studies [5] [6] [7] [8] [9] [10] ; three studies showed no difference in FPG between smokers and non-smokers [9, 11, 12] , while one study showed a lower FPG in smokers [13] ; and 2H-PG was lower in smokers in two studies [9, 11] and higher in one study [12] .
The aim of our study was to assess and quantify the influence of smoking status on mean values of HbA 1c , FPG and 2H-PG in populations of adults worldwide, and so describe the potential impact of smoking in the context of screening for diabetes by one of these glycaemic variables.
Methods

Study population The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired
Glucose Tolerance (DETECT-2) study aims to investigate the detection of type 2 diabetes using existing epidemiological studies around the world, with data on FPG and 2H-PG. In our analysis, we included 12 studies from the DETECT-2 consortium that also contained information on HbA 1c and for which the principal investigator agreed to participate, as well as two additional French studies. The studies included from DETECT-2 were: the Australian Diabetes, Obesity and Lifestyle study (AusDiab), Australia [14] ; Japanese-Brazilian Diabetes study, Brazil [15] ; a population study in Qingdao, China [16] ; The Inter99 study, Denmark [17] ; Diabetes in Egypt Study, Egypt [18] ; the Finnish cohort of the Seven Countries Study, Finland [19] ; Chennai Urban Rural Epidemiology Study (CURES), India [20] ; the Kenyan Diabetes Study, Kenya [21] ; the Hoorn Study, the Netherlands [22] ; a Tonga population-based study, Tonga [23] ; the Seattle Japanese American Community Diabetes Study, from greater Seattle, USA [24] ; and the National Health and Nutrition Examination Survey (NHANES III), USA [25] . The two additional French studies included in the analyses were the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study in a general population [26] and a study that enrolled employees from the Telecom Company in the Ile de France region [5] . All studies were approved by local ethics committees.
For the studies in Egypt and Kenya and in the French Telecom study, the questionnaires did not distinguish between ex-and never-smokers, and ex-smokers were therefore grouped with never-smokers to give two groups: current smokers and non-smokers. Data were not available on time since quitting smoking, making us unable to define ex-smokers precisely.
Assay methods for HbA 1c and glucose are detailed in the Electronic Supplementary Material (ESM) Table 1 .
The original data for participants from each study were available for analysis. We excluded participants with known diabetes and those with missing data on sex, age, BMI, smoking status, HbA 1c , FPG or 2H-PG, with one exception: the DESIR study had no data on 2H-PG. The final study population included 16,886 men and 18,539 women (35,425 participants).
Statistical analyses The populations studied are described by mean ± SD and n (%). The mean differences (95% CI) in HbA 1c , FPG and 2H-PG for ex-and current smokers in comparison with never-smokers are presented, by study, in forest plots; all studies were combined, and the mean differences were evaluated using a mixed model, with study included as a random effect. The I 2 statistic was calculated to evaluate the heterogeneity between studies [27] . We tested for interactions between smoking status with sex and with age and BMI class on the entire study population. The differences in the glycaemic variables for ex-and current smokers in comparison with never-smokers are shown, stratified by these covariates, as some of the interactions were significant. Furthermore, we evaluated the sensitivity of the results by (1) stratifying by sex and adjusting for age and BMI; (2) restricting analyses to the seven studies from Western populations with similar exposures to smoking; (3) deleting the three studies that combined never-and ex-smokers; and (4) combining ex-and neversmokers in analyses.
From the pooled data, we estimated the prevalence of screened diabetes for never-, ex-and current smokers, as defined by the three criteria: HbA 1c ≥6.5% (47.5 mmol/mol), FPG ≥7.0 mmol/l and 2H-PG ≥11.1 mmol/l. To quantify the effect of smoking on these prevalences, we calculated the mean differences between ex-and never-smokers and between current and never-smokers, for each of the three glycaemic variables. For ex-and current smokers, we then adjusted the participants' values for the three glycaemic variables, by subtracting these mean differences, to estimate the values of the glycaemic variables had each individual been a never-smoker. Thus, the mean values of the glycaemic variables were adjusted so that they were equal for never-, ex-and non-smokers. As an example, the mean FPG among ex-smokers was 0.12 mmol/l higher than for never-smokers (ESM Table 2 ); 0.12 mmol/l was subtracted from the FPG value of each ex-smoker to give an adjusted FPG value, and diabetes prevalence was calculated on these adjusted FPG values. SAS version 9.3 (Cary, NC, USA) was used in all statistical analyses. was in Japanese-American men, and the highest mean FPG (7.7±1.5 mmol/l) and 2H-PG (11.5±5.1 mmol/l) were in Japanese-Brazilian men (Tables 1 and 2 ).
Results
Characteristics
The mean HbA 1c was higher in current compared with never-smokers in ten of the 14 studies and significantly higher in seven studies; in the Egyptian study, the mean HbA 1c was 0.33% lower (significantly lower) in current smokers in comparison with never-smokers. In most studies, the mean HbA 1c (13) 131 (70) 31 (17) USA, NHANES III [25] 1988-1992 1,403 56±11 27.3±4.5 5.6±0.8 37.7±8.7 5.8±1.4 7.2±3.5 390 (28) 573 (41) 440 (31) Values are mean ± SD or n (%) Table 2 ). This relationship was consistent across sex, age and BMI strata for current smokers, but not among ex-smokers (Table 3 ).
In the study of Japanese-Brazilians, the mean FPG was significantly higher by 0.66 mmol/l in current smokers than in never-smokers, and in the Egyptian and French Telecom studies it was significantly lower by 0.55 and 0.06 mmol/l, respectively. However, in all other studies, the mean FPG did not differ between current and never-smokers (Fig. 1b , ESM Table 2 ). Combining studies, there was no significant difference in FPG between current and never-smokers; ex-smokers had a 0.12 mmol/l (0.09, 0.14) higher FPG than neversmokers, and this relationship was seen in all three age and BMI strata, and was consistent across age and BMI classes ( Table 3) .
The mean 2H-PG of current smokers was lower than that of never-smokers in all studies, except for the Indian CURES study. When the studies were combined, 2H-PG in current smokers was lower by −0.44 mmol/l (−0.52, −0.37) in comparison with never-smokers (Fig. 1c, ESM Table 2 ). These relations were consistent over sex, age and BMI strata (Table 3 ). In contrast, 2H-PG did not differ among ex-smokers and never-smokers.
When we stratified by sex, and adjusted for age and BMI, the differences in the glycaemic variables between current and never-smokers were consistent with the unadjusted differences, and were also consistent in the seven studies from 'Western' populations (ESM Table 2 ). The comparisons between ex-and never-smokers were less consistent (ESM Table 2 ).
As might be expected from Fig. 1 , we found heterogeneity among studies, with an I 2 of 93% for differences in mean HbA 1c for current smokers and 55% for ex-smokers in comparison with never-smokers; for FPG, I
2 was 71% for current smokers and 89% for ex-smokers; for 2H-PG, I 2 was 88% for current smokers and 62% for ex-smokers. We stratified by sex Fig. 1 (a) The difference in mean (95% CI) HbA 1c between current smokers and never-smokers, represented by squares in the figure, was 0.10% (0.08, 0.12) (1.1 mmol/mol [0.9, 1.3]); between ex-smokers and never-smokers, represented by diamonds in the figure, it was 0.03% (0.01, 0.05) (0.3 mmol/mol [0.1, 0.5]). The I 2 heterogeneity statistic was 93% and 55%, respectively. To convert values for HbA 1c in % into mmol/mol, subtract 2.15 and multiply by 10.929 or use the conversion calculator at www.HbA1c.nu/eng. (b) The difference in mean (95% CI) FPG between current smokers and never-smokers was −0.004 mmol/l (−0.06, 0.02); between ex-smokers and never-smokers it was 0.12 mmol/l (0.09, 0.14). The I 2 heterogeneity statistic was 71% and 89%, respectively. (c) The difference in mean (95% CI) 2H-PG between current smokers and never-smokers was −0.44 mmol/l (−0.52, −0.37); between ex-smokers and never-smokers it was 0.02 mmol/l (−0.06, 0.09). The I 2 heterogeneity statistic was 88% and 62%, respectively. France-T, French Telecom study; France-D, French DESIR study; USA-J, US Japanese-American study; USA-N, US NHANES study and adjusted for age and BMI to determine whether the resulting heterogeneity would be reduced (ESM Fig. 1-3) . This was the case for some of the comparisons; for exsmokers, the within-study heterogeneity was high in comparison with the between-study heterogeneity (ESM Table 3 ), but there were still some I 2 values of more than 90%. In a sensitivity analysis, we excluded the three studies where ex-and never-smokers were combined, but there was still high heterogeneity among studies. Furthermore, when we combined never-and ex-smokers as non-smokers, current smokers compared with non-smokers had a significantly higher HbA 1c ( As sex, age and BMI are correlated with the three glycaemic variables, we tested the interactions among smoking status and strata of these variables. Interactions with sex were significant, but those with age and BMI strata were not significant except for the relationship of smoking with age for HbA 1c (Table 3) .
Comparing current smokers with never-smokers, HbA 1c showed a significantly greater difference in men than in women, at 0.13% (95% CI 0. (Table 3 ). In contrast, while men who were exsmokers had a higher HbA 1c than never-smokers, women had a lower HbA 1c . For the three age strata, the differences were all significant comparing current and never-smokers; the differences were all positive but smaller for ex-smokers. For the three BMI strata, the HbA 1c differences were very similar for both current and ex-smokers.
When FPG was analysed according to strata, it was mainly ex-smokers for whom the FPG was significantly higher than for never-smokers; for current smokers, women had a significantly lower FPG.
For 2H-PG and current smokers, all strata had significantly lower values than never-smokers. For ex-smokers, the only significant difference was for sex (Table 3) , and these results paralleled those for HbA 1c : for ex-smokers, men had a higher and women had a lower 2H-PG than never-smokers.
For the population included in this study, we show the prevalences of screened diabetes according to each of the three glycaemic variables (Table 4) , using the original crude data and then the adjusted prevalences for ex-and current smokers, after subtracting constants from the concentrations for ex-and current smokers, so that the mean values were identical to those of never-smokers. In current smokers, the prevalence of diabetes screened by HbA 1c changed from 5.32% to 4.02%, a 1.30% lower prevalence of diabetes after this adjustment; there was no change for FPG; for 2H-PG the crude prevalence was 3.36% and the adjusted prevalence was 3.88%; thus, the prevalence was 0.52% higher after adjustment. For exsmokers, all prevalences were increased after adjustment: by 0.71% for HbA 1c , by 0.82% for FPG and by 0.16% for 2H-PG.
Discussion
Compared with never-smokers, current smokers had a 0.10% (1.1 mmol/mol) higher HbA 1c , no difference in FPG and 0.44 mmol/l lower 2H-PG. These results remained consistent when never-and ex-smokers were combined. In most of the individual studies in our analyses, the mean HbA 1c was significantly higher in current smokers than in never-smokers; for FPG, the difference between smokers and never-smokers was not significant in 11 of the 14 studies and for 2H-PG, the means were significantly lower in current smokers than in never-smokers in nine of the 14 studies. The differences in mean HbA 1c , FPG and 2H-PG between never-and exsmokers were not significant in about half of the studies.
One of the strengths of our work is the large number of participants from 14 studies from countries around the world. However, there will be measurement error in both the exposure to smoking and in the glycaemic outcome measures (HbA 1c , FPG and 2H-PG) within and across these studies.
One of the limitations of our study is the high heterogeneity across studies, with I 2 statistics, which measure the difference between individual studies, being greater than 50% for the three variables (HbA 1c , FPG and 2H-PG) for both current smokers and ex-smokers. The heterogeneity statistic I 2 was lower for some variables after stratifying for sex and adjusting for age and BMI, but remained high for others; similar results were obtained when analyses were restricted to the more comparable Western populations, and when those studies that combined ex-and never-smokers were not included in analyses. Indeed, the larger studies added greatly to the I 2 measure. As we studied mean differences in the glycaemic measures across smoking-status groups for each study, measurement error in the outcomes (differences of means) across studies because of different normal values of the assays is less likely to be a reason for high heterogeneity. There will be measurement error for smoking status, as reported in questionnaires, and as perceived by the participants who answered the questions on smoking.
Furthermore, tobacco consumption was not coded in the same way for all studies: in the French Telecom study, those who had been ex-smokers for less than 6 months were considered to be current smokers and only those who had stopped smoking for more than 6 months were considered nonsmokers; in the studies from Kenya and Egypt, ex-smokers were not coded. While the definition of never-smokers might be unambiguous, the time since ex-smokers had quit smoking might differ between studies.
There were also some differences in the outcome measures among studies. In Tonga, the OGTT was only performed in [28, 29] . Indeed, in the study of Japanese-Americans [24] , the mean HbA 1c was much higher than in other studies. HbA 1c was assayed over a long time period, and the techniques used were certainly not aligned with the recent International Federation of Clinical Chemistry standard [30] , although the assays for some studies were aligned with the National Glycohemoglobin Standardization Program that was used for the DCCT and the UK Prospective Diabetes Study [31, 32] . However, as commented above, for the main analyses shown on the forest plots, we are dealing with differences within centres in comparison with never-smokers. Finally, adding to the heterogeneity within and among studies were differences in ethnicity, socioeconomic levels, dietary habits and characteristics of participants-for example, age and BMI.
Studies that have previously examined these glycaemic measurements as a function of tobacco consumption have, in the main, found similar results to ours, despite being analysed differently and adjusted for different factors.
In the meta-analysis by Willi et al [1] , smoking was convincingly shown to be associated with an increased risk of developing type 2 diabetes, even after taking into account different confounding factors and despite the fact that diabetes was not defined homogeneously over studies; however, a causal relation cannot be assumed. Various authors have hypothesised mechanisms that might generate changes in glucose metabolism, leading to diabetes [32, 33] . Several studies have shown that smoking reduces insulin sensitivity [33, 34] , and this may be due to nicotine as it stimulates the secretion of insulin-antagonising hormones such as cortisol, catecholamines and growth hormone, which impair the action of insulin [33] . However Wareham et al concluded that a causal relationship is unlikely [11] , as the relationship was attenuated after adjusting for age and BMI. Alterations in insulin secretion have not been shown to be associated with smoking [33] . It is also probable that smokers have other unhealthy behaviours and dietary habits as well as a low socioeconomic status, and these are well-recognised risk factors for diabetes [1] .
It is of note that we (and others) have found associations between smoking and HbA 1c and 2H-PG in opposing directions. One can speculate that HbA 1c assay techniques might be affected by a metabolite of tobacco. A study in smokers and non-smokers using the International Federation of Clinical Chemistry reference assay, which analyses only one molecular species of glycated A 1c , would confirm or refute this hypothesis. Higgins et al have hypothesised that smoking might induce increased permeability of the erythrocyte membrane to the passage of glucose, thus increasing HbA 1c [35] . Smoking has been associated with both lower arterial oxygen saturation and higher erythrocyte 2,3-diphosphorglycerate concentrations. In vitro studies have demonstrated that deoxyhaemoglobin is glycated more rapidly than oxyhaemoglobin [36] , and the rate of HbA 1c formation is increased with elevated 2,3-diphosphorglycerate concentrations. Another possibility is the effect of tobacco smoking on erythrocyte lifespan. Carbon monoxide, administered to two patients with sickle-cell disease, was found to increase erythrocyte lifespan [37] . Further studies are needed to assess the role of these factors.
Some authors have reported that smoking inhibits gastric motor activity [38, 39] and may therefore affect the rate at which a meal (or the glucose in an OGTT) is absorbed. Other authors have studied the effect of tobacco on solid and liquid meals separately, and found that cigarette smoking accelerates the emptying of the liquid component of meals [40] . In agreement with this report, Janzon et al showed a dose-response relationship between glucose and habitual cigarette consumption at 40 min following an OGTT, and the inverse relationship at 120 min, indicating a quicker absorption of glucose [41] . This was corroborated in the EGIR-RISC STUDY [42] : age-, sex-and BMI-adjusted glucose concentrations were identical at fasting in current and never-smokers, significantly higher in current smokers at 30 and 60 min, no difference between the two groups at 90 min and significantly lower in current smokers at 120 min (B. Balkau, unpublished data); smokers therefore appear to have accelerated gastric emptying during an OGTT. Furthermore, the area under the glucose curve during the OGTT was significantly higher in current smokers, and this would presumably lead to a higher HbA 1c . Overall in our study population, using data from our study, screening for diabetes using HbA 1c , rather than the formerly considered gold standard of 2H-PG, would result in a 1.8% higher prevalence of diabetes in current smokers, due to the higher HbA 1c and lower 2H-PG levels in current smokers. Using HbA 1c as a screening test should have the beneficial effect of preferentially identifying current smokers with high HbA 1c , and so provide the possibility for early preventive measures with an encouragement to stop smoking. For ex-smokers, both HbA 1c and 2H-PG levels were higher than in neversmokers, with a net difference of 0.55% in prevalence.
In conclusion, previous publications have shown that smoking is associated with an increased risk of diabetes. In our meta-analysis, we found that HbA 1c levels were higher in smokers than in non-smokers; this was not the case for FPG and indeed 2H-PG levels were lower. The mechanisms explaining the higher level of HbA 1c and the lower level of 2H-PG in smokers need to be further explored.
